http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4db34697ef248332050d72b67a959369
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Polyak |
| name | Kornelia Polyak |
| given-name | Kornelia |
| organization-name | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02115; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 1Medical Oncology and Departments of; 3Department of Medicine, Harvard Medical School; 6Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 6Dana-Farber Cancer Institute Harvard Medical School, Boston, Massachusetts 3Department of Medical Oncology,; 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Harvard Medical School, Boston, Massachusetts; and Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital; 4Department of Medicine, Harvard Medical School; 5Department of Biostatistics, Harvard School of Public Health, Boston; 6Departments of Physics and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; 7Harvard Stem Cell Institute, Cambridge, Massachusetts; 8Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Departments of 9Pathology and 10Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; 11Department of Medical Oncology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; 12Department of Pathology, MizMedi Hospital, Seoul, South Korea; 13Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; and 14Hubrecht Institute, Royal Netherlan; Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital; 4Department of Medicine, Harvard Medical School; 5Department of Biostatistics, Harvard School of Public Health, Boston; 6Departments of Physics and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; 7Harvard Stem Cell Institute, Cambridge, Massachusetts; 8Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Departments of 9Pathology and 10Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; 11Department of Medical Oncology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; 12Department of Pathology, MizMedi Hospital, Seoul, South Korea; 13Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; and 14Hubrecht Institute, Royal Netherlan; Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital; 4Department of Medicine, Harvard Medical School; 5Department of Biostatistics, Harvard School of Public Health, Boston; 6Departments of Physics and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; 7Harvard Stem Cell Institute, Cambridge, Massachusetts; 8Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Departments of 9Pathology and 10Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; 11Department of Medical Oncology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; 12Department of Pathology, MizMedi Hospital, Seoul, South Korea; 13Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; and 14Hubrecht Institute, Royal Netherlan; Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital; 4Department of Medicine, Harvard Medical School; 5Department of Biostatistics, Harvard School of Public Health, Boston; 6Departments of Physics and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; 7Harvard Stem Cell Institute, Cambridge, Massachusetts; 8Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Departments of 9Pathology and 10Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; 11Department of Medical Oncology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; 12Department of Pathology, MizMedi Hospital, Seoul, South Korea; 13Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; and 14Hubrecht Institute, Royal Netherlan Departments of aMedical Oncology and; Harvard Medical School, Boston, MA 02115; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 4BBS Program, Harvard Medical School, Boston, Massachusetts.; 13Broad Institute, Cambridge, Massachusetts. The Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.; Department of Biostatistics, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.; GeneGo, St. Joseph, MI 49085, USA.; Vavilov Institute of General Genetics, Moscow, Russia.; Department of Biomedical Engineering, Institute of Computational Medicine, Johns Hopkins University, Baltimore, MD 21218, USA. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea; 2Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea; Departments of 3Medical Oncology and 4Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 5Harvard Medical School, and 6Harvard School of Public Health, Boston, Massachusetts; Authors' Affiliations: 1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea; 2Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea; Departments of 3Medical Oncology and 4Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 5Harvard Medical School, and 6Harvard School of Public Health, Boston, Massachusetts Authors' Affiliations: 1Thomson Reuters, Healthcare & Life Science, St. Joseph, Michigan; 2Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts; and 3Ludwig Center at Johns Hopkins, Johns Hopkins Medical School, Johns Hopkins University, Baltimore, Maryland 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 3Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 8Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; 11Harvard Stem Cell Institute, Cambridge, Massachusetts.; 12Broad Institute, Cambridge, Massachusetts. Departments of aMedical Oncology and; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115;; Department of Medicine, Harvard Medical School, Boston, MA 02115;; Harvard Stem Cell Institute, Cambridge, MA 02138 Departments of aMedical Oncology and; Departments of cMedicine,; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA Department of Medical Oncology, Harvard Medical School and; Dana Farber Cancer Institute, Boston, MA 02215; and 1Medical Oncology and Departments of; 4Harvard Medical School; and 5Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 9Harvard Stem Cell Institute, Cambridge, Massachusetts. Duke University Medical Center, Durham, NC 27710; Ludwig Institute for Cancer Research, Sao Paulo 01509-010, SP, Brazil; Office of Cancer Genomics and Center for Bioinformatics, National Cancer Institute, Bethesda, MD 20892; Dana–Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; and Laboratory of Biological Chemistry, National Institute on Aging, 5600 Nathan Shock Drive, Baltimore, MD 21224 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 17The Broad Institute, Cambridge, Massachusetts.; 18Harvard Stem Cell Institute, Cambridge, Massachusetts. Department of Medical Oncology Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA USA 4Dana-Farber Cancer Institute,; 5Harvard Medical School, Boston, Massachusetts; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; Authors' Affiliations: 1Department of Biostatistics and Computational Biology and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Biostatistics, Harvard School of Public Health; 4Department of Medicine, Brigham and Women's Hospital; 5Department of Medicine, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Department of Biostatistics and Computational Biology and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Biostatistics, Harvard School of Public Health; 4Department of Medicine, Brigham and Women's Hospital; 5Department of Medicine, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Department of Biostatistics and Computational Biology and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Biostatistics, Harvard School of Public Health; 4Department of Medicine, Brigham and Women's Hospital; 5Department of Medicine, Harvard Medical School, Boston, Massachusetts Medical Oncology Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA. Department of Medical Oncology; Dana-Farber Cancer Institute, Harvard Medical School; Boston MA USA 1Medical Oncology and Departments of; 3Harvard Medical School, Boston, Massachusetts; 1Department of Medical Oncology, Dana-Farber Cancer Institute,; 2Harvard Medical School, and Department of Medical Oncology, Dana–Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;; Harvard Stem Cell Institute, Cambridge, MA 02138; and 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215;, , Authors' Affiliations: Departments of 1Medical Oncology, 2Biostatistics and Computational Biology, and 3Radiation Oncology, Dana- Farber Cancer Institute; 4Department of Medicine, Brigham and Women's Hospital; Departments of 5Medicine and 6Pathology, Harvard Medical School; 7Department of Biostatistics, Harvard School of Public Health; Departments of 8Pathology and 9Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 10Obstetrics and Gynaecology Department, Hospitais da Universidade de Coimbra, Coimbra, Portugal; 11Gulbenkian Programme for Advanced Medical Education, Portugal; 12King's College, University of Cambridge, Cambridge, United Kingdom; 13Department of Medical Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 14Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; 15Department of Pathology, Seoul National University College of Medicine, Seoul; 16Department of Pathology, Seoul; Authors' Affiliations: Departments of 1Medical Oncology, 2Biostatistics and Computational Biology, and 3Radiation Oncology, Dana- Farber Cancer Institute; 4Department of Medicine, Brigham and Women's Hospital; Departments of 5Medicine and 6Pathology, Harvard Medical School; 7Department of Biostatistics, Harvard School of Public Health; Departments of 8Pathology and 9Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 10Obstetrics and Gynaecology Department, Hospitais da Universidade de Coimbra, Coimbra, Portugal; 11Gulbenkian Programme for Advanced Medical Education, Portugal; 12King's College, University of Cambridge, Cambridge, United Kingdom; 13Department of Medical Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 14Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; 15Department of Pathology, Seoul National University College of Medicine, Seoul; 16Department of Pathology, Seoul; Authors' Affiliations: Departments of 1Medical Oncology, 2Biostatistics and Computational Biology, and 3Radiation Oncology, Dana- Farber Cancer Institute; 4Department of Medicine, Brigham and Women's Hospital; Departments of 5Medicine and 6Pathology, Harvard Medical School; 7Department of Biostatistics, Harvard School of Public Health; Departments of 8Pathology and 9Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 10Obstetrics and Gynaecology Department, Hospitais da Universidade de Coimbra, Coimbra, Portugal; 11Gulbenkian Programme for Advanced Medical Education, Portugal; 12King's College, University of Cambridge, Cambridge, United Kingdom; 13Department of Medical Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 14Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; 15Department of Pathology, Seoul National University College of Medicine, Seoul; 16Department of Pathology, Seoul; Authors' Affiliations: Departments of 1Medical Oncology, 2Biostatistics and Computational Biology, and 3Radiation Oncology, Dana- Farber Cancer Institute; 4Department of Medicine, Brigham and Women's Hospital; Departments of 5Medicine and 6Pathology, Harvard Medical School; 7Department of Biostatistics, Harvard School of Public Health; Departments of 8Pathology and 9Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 10Obstetrics and Gynaecology Department, Hospitais da Universidade de Coimbra, Coimbra, Portugal; 11Gulbenkian Programme for Advanced Medical Education, Portugal; 12King's College, University of Cambridge, Cambridge, United Kingdom; 13Department of Medical Oncology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 14Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; 15Department of Pathology, Seoul National University College of Medicine, Seoul; 16Department of Pathology, Seoul Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA USA; Department of Medicine Harvard Medical School Boston MA USA Cell Biology and Genetics Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021. Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA Authors' Affiliations: Departments of 1Cancer Biology, 2Medical Oncology, and 3Biostatistic and Computational Biology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 5Harvard Medical School, 6Department of Pathology, Brigham and Women's Hospital, 7Harvard School of Public Health, Boston, Massachusetts; 8Department of Pathology, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Gyeonggi, South Korea; 9Department of Pathology, Samsung Medical Center, Seoul, South Korea; and 10Department of Pathology, Washington University School of Medicine, St. Louis, Missouri; Authors' Affiliations: Departments of 1Cancer Biology, 2Medical Oncology, and 3Biostatistic and Computational Biology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 5Harvard Medical School, 6Department of Pathology, Brigham and Women's Hospital, 7Harvard School of Public Health, Boston, Massachusetts; 8Department of Pathology, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Gyeonggi, South Korea; 9Department of Pathology, Samsung Medical Center, Seoul, South Korea; and 10Department of Pathology, Washington University School of Medicine, St. Louis, Missouri; Authors' Affiliations: Departments of 1Cancer Biology, 2Medical Oncology, and 3Biostatistic and Computational Biology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 5Harvard Medical School, 6Department of Pathology, Brigham and Women's Hospital, 7Harvard School of Public Health, Boston, Massachusetts; 8Department of Pathology, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Gyeonggi, South Korea; 9Department of Pathology, Samsung Medical Center, Seoul, South Korea; and 10Department of Pathology, Washington University School of Medicine, St. Louis, Missouri The Johns Hopkins Oncology Center and The Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21231; National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; Department of Medicine and Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44106; and Ludwig Institute for Cancer Research, The Cancer Center and Department of Medicine, University of California at San Diego School of Medicine, La Jolla, CA 92093 Departments of Medical Oncology and Biostatistics, Dana–Farber Cancer Institute, Department of Pathology and Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, and Departments of Medicine and Pathology, Harvard Medical School and Harvard School of Public Health, Boston, MA 02115; Comprehensive Cancer Center, University of California, San Francisco, CA 94143; Departments of Pathology and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of... Authors' Affiliations: 1Department of Pathology, Beth Israel Deaconess Medical Center; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Authors' Affiliations: 1Department of Pathology, Beth Israel Deaconess Medical Center; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Authors' Affiliations: 1Department of Pathology, Beth Israel Deaconess Medical Center; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts Author's Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts Departments of Adult Oncology and Biostatistics, Dana–Farber Cancer Institute, Boston, MA 02115; Departments of Surgery and Pathology, Brigham and Women's Hospital, Boston, MA 02115; Department of Pathology, Beth-Israel Deaconess Medical Center, Boston, MA 02115; Department of Medicine, Children's Hospital, Boston, MA 02115; Department of Pathology, Massachusetts General Hospital, Charlestown, MA 02129; Department of Medicine, Harvard Medical School, Boston, MA 02115; Harvard School of... From the Department of Adult Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; and Department of Pathology, Duke University Medical Center, Durham, NC. 2Medical Oncology and; 4Harvard Medical School; 1Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 3BBS Program, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, USA. Department of Medicine, Brigham and Women's Hospital, Boston, USA. 2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. 5Dana-Farber Cancer Institute, Boston, Massachusetts. Dana‐Farber Cancer Institute Boston Massachusetts 5Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts |
Incoming Links
Total number of triples: 255.